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Background. No systematic studies exist on sex and gender differences across a broad range of travel-associated
diseases.
Methods. Travel and tropical medicine GeoSentinel clinics worldwide contributed prospective, standardized
data on 58,908 patients with travel-associated illness to a central database from 1 March 1997 through 31 October
2007. We evaluated sex and gender differences in health outcomes and in demographic characteristics. Statistical
significance for crude analysis of dichotomous variables was determined using x 2 tests with calculation of odds
ratios (ORs) and 95% confidence intervals (CIs). The main outcome measure was proportionate morbidity of
specific diagnoses in men and women. The analyses were adjusted for age, travel duration, pretravel encounter,
reason for travel, and geographical region visited.
Results. We found statistically significant ( ) differences in morbidity by sex. Women are proportionatelyP ! .001
more likely than men to present with acute diarrhea (OR, 1.13; 95% CI, 1.09–1.38), chronic diarrhea (OR, 1.28;
95% CI, 1.19–1.37), irritable bowel syndrome (OR, 1.39; 95% CI, 1.24–1.57), upper respiratory tract infection
(OR, 1.23; 95% CI, 1.14–1.33); urinary tract infection (OR, 4.01; 95% CI, 3.34–4.71), psychological stressors (OR,
1.3; 95% CI, 1.14–1.48), oral and dental conditions, or adverse reactions to medication. Women are proportionately
less likely to have febrile illnesses (OR, 0.15; 95% CI, 0.10–0.21); vector-borne diseases, such as malaria (OR, 0.46;
95% CI, 0.41–0.51), leishmaniasis, or rickettsioses (OR, 0.57; 95% CI, 0.43–0.74); sexually transmitted infections
(OR, 0.68; 95% CI 0.58–0.81); viral hepatitis (OR, 0.34; 95% CI, 0.21–0.54); or noninfectious problems, including
cardiovascular disease, acute mountain sickness, and frostbite. Women are statistically significantly more likely to
obtain pretravel advice (OR, 1.28; 95% CI, 1.23–1.32), and ill female travelers are less likely than ill male travelers
to be hospitalized (OR, 0.45; 95% CI, 0.42–0.49).
Conclusions. Men and women present with different profiles of travel-related morbidity. Preventive travel
medicine and future travel medicine research need to address gender-specific intervention strategies and differential
susceptibility to disease.
A total of 903 million international tourist arrivals were
recorded in 2007 [1]. In general, more men than wom-
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en travel; 53% of 130 million US outbound travel-
ers are male. Men predominate in business travel (ac-
counting for 74% of business travelers) [2]. Travel is
associated with an increased risk of health problems,
and although most illnesses are self-limiting, ∼8% of
travelers will require medical attention [3]. Most studies
of ill travelers provide few detailed data on sex and
gender. In the online medical literature databases for
the period 1983–2008, there are no systematic studies
a Members of the GeoSentinel Surveillance Network who contributed data are
listed at the end of the text.
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on sex differences in travelers across a broad range of health
risks, yet being male or female is an important human variable
that affects health and illness. Differences between the sexes in
the incidence and severity of infection will be related to genetic
and physiological constitutions [4] but also to differences in
exposures, attractiveness to vectors, routes of pathogen entry,
processing of pathogens and cellular responses, participation
in high-risk activities, and use of preventive strategies. In terms
of travel-associated morbidity, we sought to determine whether
there are sex and gender differences in travel characteristics,
presenting symptoms, and diagnoses and whether potentially
gender-associated behavioral patterns could be identified. Our
study confirmed sex-associated symptoms and diagnoses and
showed differing behavioral patterns in men and women in the
context of travel-associated illness.
METHODS
We analyzed data from the GeoSentinel network’s 44 sites [5]
from 1 March 1997 through 31 October 2007 according to
demographic characteristics and travel related morbidity. A
GeoSentinel site is a clinic specializing in travel or tropical
medicine that contributes clinician-based data on ill travelers
seen during or after travel.
Inclusion criteria. To be eligible, patients must have
crossed an international border 10 years before presentation
and must have sought medical advice for a presumed travel-
related illness. Only final, confirmed, and probable diagnoses
were considered, and 11 diagnosis per patient was possible.
Final diagnoses were assigned by a physician.
Data were collected according to a standardized, anonymous
questionnaire and entered into a Structured Query Language
database. The questionnaire comprises demographic data (age,
sex, country of birth, country of residence, current citizenship),
travel history during the previous 5 years, inpatient or out-
patient status, major clinical symptom (11 symptom per patient
is possible), pretravel encounter for travel health advice, reason
for most recent travel, and patient classification. Included in
the analysis were those individuals who traveled for tourism,
to visit friends and relatives, for business, for research or ed-
ucation, for military purposes, and for missionary or volunteer
work. Those individuals who traveled for immigration were
excluded.
Diagnostic categories. Final diagnoses were assigned a di-
agnostic code from a standardized list of 1500 diagnoses, which
were also categorized into 21 broad syndrome groups. Sum-
mary diagnosis “respiratory tract infections” includes upper
and lower respiratory infections; “malaria” includes infections
with all malaria species; “diarrhea” includes acute diarrhea of
parasitic, viral, bacterial, or unknown origin; “hepatitis” in-
cludes chronic or acute viral hepatitis; “viral syndrome” in-
cludes nonspecific viral symptoms; “AIDS/HIV/STI” includes
asymptomatic human immunodeficiency virus (HIV) infection,
acute HIV infection, AIDS, gonorrhea, syphilis, and other sex-
ually transmitted infections (STIs). Syndrome groups, such as
“dermatologic disorder,” were defined as previously described
[6].
Statistical analysis. The data were analyzed using SPSS
software, version 15 (SPSS). Statistical significance for crude
analysis of dichotomous variables was determined using x2 tests
with calculation of odds ratios (ORs) and 95% confidence in-
tervals (CIs). Multivariate analysis with logistic regression was
performed to adjust data for factors that were statistically sig-
nificant on univariate testing. The logistic regression results for
female versus male individuals were adjusted for age, travel
duration (130 days vs !30 days), whether the individual was
seen during or after travel, pretravel encounter, reason for
travel, and geographical region visited. Proportionate morbidity
was calculated as the number of patients with a specific or a
summary diagnosis as a proportion of all men or women, re-
spectively, expressed per 1000 patients.
RESULTS
There were a total of 58,908 travelers included in the analysis;
50.3% were female, and 49.7% were male.
Demographic characteristics. Female travelers were more
likely than male travelers to be younger, have a shorter duration
of travel, be tourists, have pretravel health advice, and present
during travel and were less likely than male travelers to be
treated as an in-patient (Table 1). There was no statistically
significant difference between proportions of men and women
who reported high-risk travel (eg, backpacking or off-track
travel).
Diagnosis. Women had a higher proportionate morbidity
for all types of diarrhea and respiratory morbidity (except pneu-
monia). Men, however, had a significantly higher proportionate
morbidity for all febrile illnesses, including the vector-trans-
mitted diseases, such as malaria, dengue, rickettsioses, and
leishmaniasis. Male travelers had a higher risk of acute hepatitis
A, chronic viral hepatitis, and any STI, whereas women were
more susceptible to urinary tract infections. With regard to
noncommunicable health risks, there were significant differ-
ences between the sexes. Women were more likely to present
with psychological stressors, adverse reactions to medications,
and oral and dental conditions, whereas men presented with
an excess of acute mountain sickness and frost bite (Table 2
and Figure 1).
DISCUSSION
Differing behavior, cognition, metabolism, responses to med-
ication or vaccines, and susceptibility to infectious disease lead
to distinct profiles of travel-associated morbidity for men and
women. These differences are related to sex, gender, or both.
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Table 1. Demographic Characteristics of Ill Travelers Presenting During and After Travel at Geo-
Sentinel Clinics Worldwide
Variable
Female patients
(n p 29,643)
Male patients
(n p 29,265) P ORa (95% CI)
Percentage of total patients 50.3 49.7
Age
Mean years 34.4 35.9 !.001
30 years old 14,061 (53.9) 12,014 (46.1) !.001 1.30 (1.25–1.33)
Reason for travel
Business 6195 (20.9) 8206 (28.0) !.001 0.68 (0.65–0.70)
Health 461 (1.6) 419 (1.4) .220 1.09 (0.95–1.24)
Military 4 (!0.1) 34 (0.1) !.001 0.12 (0.04–0.33)
Missionary 3421 (11.5) 2845 (9.7) !.001 1.21 (1.15–1.28)
Student 545 (1.8) 403 (1.4) !.001 1.34 (1.18–1.53)
Tourism 19,017 (64.2) 17,358 (59.3) !.001 1.23 (1.19–1.27)
Travel risk level
Expatriate 6487 (21.9) 7107 (24.3) !.001 0.87 (0.84–0.91)
Prearranged or organized travel 2435 (8.2) 3787 (12.9) !.001 0.60 (0.57–0.64)
Risk travel 1088 (3.7) 1102 (3.8) .540 0.97 (0.89–1.06)
Ill and presenting during travel 12,952 (43.7) 12,153 (41.5) !.001 1.09 (1.06–1.13)
In-patient 1338 (4.6) 2762 (9.5) !.001 0.45 (0.42–0.49)
Pretravel encounter 17,151 (68.2) 15,425 (62.7) !.001 1.28 (1.23–1.32)
Duration of travel 130 days 9894 (42.4) 9649 (42.4) .970 1.00 (0.96–1.04)
Region of travel
Pacific 942 (3.2) 1041 (3.6) .100 0.89 (0.81–0.97)
Latin America 3915 (13.2) 3913 (13.4) .600 0.99 (0.94–1.03)
Europe 3625 (12.2) 3343 (11.4) .002 1.08 (1.03–1.14)
North America 1356 (4.6) 1261 (4.3) .120 1.07 (0.98–1.15)
Africa 5462 (18.4) 5652 (19.3) .006 0.94 (0.91–0.98)
Asia 14921 (50.3) 14509 (49.6) .070 1.03 (1.0–1.07)
NOTE. Data are no. (%) of patients, unless otherwise indicated. The mean time to presentation did not differ significantly
between men and women. The following data were missing: age, 207 patients; risk level qualifier, 36,902 patients; in-
patient, 687 patients; pretravel encounter, 9131 patients; duration of travel, 12,833 patients. CI, confidence interval; OR,
odds ratio.
a All ORs are for traveler being female versus male.
Sex is biologically determined (the sexual genotype is XX in
the female and XY in the male), but gender relates to a person’s
self-representation as male or female and to the manner in
which social institutions influence that person. Gender is
shaped by environment and experience [7]. Our study is, to
our knowledge, the first to explore the spectrum of travel-
related illness in terms of sex and gender, and with the use
standard analyses, we found statistically significant differences
in the spectrum of travel-associated illness in men and women.
We found that ill women who presented to travel clinics were
significantly more likely to have sought pretravel advice than
were their male counterparts (OR, 1.28; 95% CI, 1.23–1.32).
Other studies have also shown that female sex is independently
associated with receiving pretravel health information [8] and
also with increased concern about travel stressors [9]. In ad-
dition, as shown by their predominance in the GeoSentinel
collective, women, compared with men, present more often
after travel with presumed travel-associated morbidity, but ei-
ther their conditions are more benign or medical services treat
men differently, because men are more likely than women to
be treated as in-patients or referred to hospitals [9, 10]. One
study of travel-related hospitalizations [10] found that 71% of
hospitalizations were of male patients. We found no significant
differences in the numbers of deaths recorded for men and
women in our analysis, but studies on travel-related deaths [11,
12] and road traffic accidents [13] show that such events pre-
dominantly involve men.
Our study showed that women who present to travel clinics
are more likely than men to report an adverse event related to
medication (OR, 1.39; 95% CI, 1.11–1.73), and this has been
borne out by the literature, particularly regarding the tolera-
bility of medications used for malaria prophylaxis (specifically,
mefloquine, for which several studies have shown significantly
poorer tolerability among women than among men) [14–16].
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Table 2. Comparison of Diagnoses in Ill Female and Male Travelers Who Presented to GeoSentinel
Clinics Worldwide
Diagnoses in travelers
No. (%) of patients, by sex
OR (95% CI)
Female
(n p 29,643)
Male
(n p 29,265)
Diarrhea
Acute diarrhea 7290 (24.6) 6322 (21.6) 1.13 (1.09–1.38)
Acute bacterial diarrhea 3681 (12.4) 3257 (11.1) 1.06 (1.0–1.11)
Acute parasitic diarrhea 1712 (5.8) 1485 (5.1) 1.14 (1.06–1.23)
Acute unspecific diarrhea 2039 (6.9) 1713 (5.9) 1.18 (1.10–1.26)
Chronic diarrhea 1922 (6.5) 1543 (5.3) 1.28 (1.19–1.37)
Irritable bowel syndrome 679 (2.3) 502 (1.7) 1.39 (1.24–1.57)
Respiratory morbidity
Acute respiratory infection 3437 (11.6) 3122 (10.7) 1.08 (1.03–1.14)
Upper respiratory tract infection 1504 (5.1) 1188 (4.1) 1.23 (1.14–1.33)
Pneumonia 215 (0.7) 391 (1.3) 0.53 (0.46–0.64)
Fever, vector borne Infection
Febrile systemic illness 3357 (11.3) 5082 (17.4) 0.64 (0.61–0.67)
Malaria 455 (1.5) 1004 (3.4) 0.46 (0.41–0.51)
Dengue 514 (1.7) 915 (3.1) 0.63 (0.56–0.71)
Rickettsia 81 (0.3) 150 (0.5) 0.57 (0.43–0.75)
Leishmania 84 (0.3) 150 (0.5) 0.57 (0.43–0.74)
Febrile exanthem 34 (0.1) 304 (1.0) 0.15 (0.10–0.21)
Genitourinary
Urinary tract infection 744 (2.5) 188 (0.6) 4.01 (3.34–4.71)
STI (AIDS, HIV infection, syphilis, gonorrhea) 239 (0.8) 362 (1.2) 0.68 (0.58–0.81)
Acute HIV infection 7 (!.01) 38 (1.0) 0.20 (0.09–0.44)
Other condition
Frostbite 21 (0.1) 145 (0.5) 0.14 (0.09–0.22)
Mountain sickness 298 (1.0) 525 (1.8) 0.54 (0.47–0.63)
Psychological problems 527 (1.8) 403 (1.4) 1.30 (1.14–1.48)
Anxiety/fatigue 877 (3.0) 696 (2.4) 1.27 (1.15–1.41)
Cardiovascular disease 211 (0.7) 411 (1.4) 0.56 (0.47–0.66)
NOTE. A total of 44 GeoSentinel sites on 6 continents contributed data to the central database. for all variables,P ! .001
adjusted for age, travel duration (130 days vs !30 days), whether the individuals was seen during or after travel, pretravel
encounter, reason for travel, and geographical region visited. CI, confidence interval; HIV, human immunodeficiency virus;
OR, odds ratio; STI, sexually transmitted infection.
Men were proportionally more likely to have febrile systemic
illness (OR, 1.6), and a recent study on fever in travelers showed
that 58% of ill travelers who presented with fever were male
and that 71% of those who present with fever and malaria are
male [17]. Several studies have shown that men are more likely
than women to acquire malaria [18, 19], leishmaniasis [20],
and West Nile virus infection [21] than are women. One study
of leptospirosis involving German travelers found that male sex
was associated with a higher severity of clinical disease not
related to differences in exposure risks or health-seeking be-
havior [4]. Malaria infection in men is also more severe, with
men being more likely than women to die from malaria [10,
22, 23]. Male travelers are also at greater risk of infection with
multiple clones of Plasmodium falciparum [24]. Female mos-
quitoes, including the malaria-transmitting Anopheles and the
dengue-transmitting Aedes (Stegomia)) need blood for the de-
velopment of their eggs, and their host-seeking behavior has
been perfected over centuries of evolution. There are several
reasons why men may be more attractive hosts than women
for mosquitoes. It is known that mosquitoes identify their hosts
by use of a variety of cues, the most important being olfactory.
Identified olfactory cues are carbon dioxide, sweat, and volatile
skin products, and men produce more of these mosquito at-
tractants than do women. This has been suggested as a bio-
logical factor that increases male susceptibility to mosquito-
borne infection. Furthermore, repellents are water-soluble, and
individuals who sweat profusely (mainly men) will need to re-
apply repellents frequently. Other analyses have suggested that
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Figure 1. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for diagnoses profiles for female and male travelers. ORs (for female versus
male travelers) are squares (filled squares show illnesses more likely to occur in men, and open squares show illnesses more likely to occur in women),
and 95% CIs are lines; diagnoses profiles in female and male travelers are adjusted for age, travel duration, region of travel, reason for travel,
pretravel encounter, and whether the individual was seen at a GeoSentinel site during or after travel. Delusional, delusional parasitosis; HIV, human
immunodeficiency virus infection.
male predominance in travelers’ malaria is attributable to risk-
taking behavior [10] or to poorer adherence to personal pro-
tection measures against mosquito bites and chemoprophylactic
medication. With regard to diarrhea and gastrointestinal illness,
there is some literature that shows that female sex is a predictor
of diarrhea and gastrointestinal illness [25, 26]. However, other
epidemiological studies [27] and a recent retrospective survey
found no association between sex and diarrhea [28], perhaps
because of the small sample size included in that study (np
). It is unclear whether women practice travel behavior that108
increases the risk of acquiring gastrointestinal pathogens or
whether they are more likely than men to seek medical help
for gastrointestinal problems. Salmonella Typhi infections have
been reported to occur more frequently among men than
among women [29, 30], but our study found only a small,
nonsignificant excess of Salmonella Typhi infection among male
individuals ( ). A recent study of amebic dysenteryPp .100
prompted by the observation that men are 17 times more likely
to develop amebic liver abscess or amebic dysentery than are
women found biological differences: serum from women was
significantly more effective in killing Entamoeba histolytic tro-
phozoites than was serum from men [31].
With regard to STIs, several studies have shown that male
travelers are more likely to have casual sex than are female
travelers [32–34]. A British study found that 13.9% of men
and 7.1% of women have new sexual partners while overseas
[34]. Among respondents who were younger (aged 16–24 years)
and never married, the proportions were significantly higher
(23% and 17%, respectively). Clearly, sexual health promotion
needs more attention from pretravel health advisors.
GeoSentinel collects data on a large sentinel sample of ill
travelers and uses proportionate morbidity as an indicator of
likely diagnoses occurring in travelers. The strength of the
GeoSentinel database lies in the clinically verified data on a
large number of travelers and diseases. Our study, however, has
some limitations. Chiefly, these are that only a proportional
sample of cases of disease is captured and that the use of the
proportionate morbidity ratio does not allow for the calculation
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of absolute risk or true incidence rates of disease, because de-
nominator data are not available. Many returned travelers, par-
ticularly those with mild or self-limiting conditions, are seen
in nonspecialized, general practice. Some conditions with a
short incubation period will be treated during travel, and in-
dividuals with those conditions may not present to the network
clinics. GeoSentinel sites are usually located within academic
centers, and many patients with imported illness that is neither
mild nor self-limited but is suggestive of an exotic imported
disease will present spontaneously or are referred by general
practitioners. This does introduce some selection and reporting
bias. However, this is not a key factor in the current analysis,
because we are comparing proportionate morbidity of disease
in men and women, and the selection bias will apply to both
sexes.
A further study limitation is that the identified differences
in morbidities between men and women could not clearly be
attributed to sex (ie, biological) or gender (ie, cultural) factors.
New research is indicated. Furthermore, we have few data on
death and injury sustained by men and women, and injury is
recognized as a major cause of morbidity among travelers.
Although it can be difficult to disentangle the effects of sex
and gender on health risks, this study has found significant
differences in travel-associated morbidity between men and
women. Certain conditions, such as the predominance of uri-
nary tract infection in women, can likely be explained by in-
herent differences in physiology and anatomy. However, higher
proportional risks among men for febrile illnesses, vector-borne
diseases, viral hepatitis, or sexually transmitted infections and
the higher proportion of women who present with diarrhea,
acute respiratory infection, oral or dental conditions, adverse
events related to medication, or psychological problems warrant
further investigation. Exploring these sex differences and the
cultural influences that foster more-risky behavior among male
individuals will open new avenues of research. Practical im-
plications for preventive and therapeutic travel medicine prac-
tice are as follows: female travelers should be prepared to self-
treat urinary tract infection and can be predicted to need more
anti-diarrhea treatment. The pretravel advice should provide
concise information on the tolerability of medication and how
this may vary between the sexes, and dosage adjustments may
be needed for women with low body weight. All travelers need
advice on mosquito-transmitted infections, but men need to
be particularly sensitized regarding adherence to mosquito bite
prevention measures and the need for frequent application of
repellents. Safe sex advice is a missing component in most
pretravel practices, and our study suggests that male travelers,
in particular, would benefit from greater preventive efforts. Our
study has significant implications for travel medicine and can
be used to prioritize prevention advice based on gender sus-
ceptibility to travel-related conditions.
GEOSENTINEL SURVEILLANCE NETWORK
In addition to the authors, members of the GeoSentinel Sur-
veillance Network who contributed data (in descending order)
are as follows: Kevin C. Kain, University of Toronto, Toronto,
Canada; Louis Loutan and Franc¸ois Chappuis, University of
Geneva, Geneva, Switzerland; Susan MacDonald, Beijing
United Family Hospital and Clinics, Beijing, Peoples Republic
of China; Poh Lian Lim and Annelies Wilder-Smith, Tan Tock
Seng Hospital, Singapore; DeVon C. Hale and Stefanie S. Gel-
man, University of Utah, Salt Lake City, Utah; Graham Brown
and Joseph Torresi, Royal Melbourne Hospital, Melbourne,
Australia; Bradley A. Connor, Cornell University, New York,
New York; Phyllis E. Kozarsky and Carlos Franco-Paredes,
Emory University, Atlanta, Georgia; Robert Steffen, University
of Zu¨rich, Zu¨rich, Switzerland; Hiroko Sagara, Yokohama Mu-
nicipal Citizen’s Hospital, Yokohama, Japan; Philippe Parola,
Fabrice Simon, and Jean Delmont, Hoˆpital Nord, Marseille,
France; Michael D. Libman and J. Dick Maclean, McGill Uni-
versity, Montreal, Canada; Marc Shaw, Worldwise Travellers
Health and Vaccination Centre, Auckland, New Zealand; N.
Jean Haulman, David Roesel, and Elaine C. Jong, University
of Washington, Seattle, Washington; Giampiero Carosi and
Francesco Castelli, University of Brescia, Brescia, Italy; Gerd-
Dieter Burchard, Bernhard-Nocht-Institute for Tropical Med-
icine, Hamburg, Germany; Robert Kass, Travellers Medical and
Vaccination Centres of Australia, Adelaide, Australia (Decem-
ber 1997–March 2001 only); Elizabeth D. Barnett, Boston Uni-
versity, Boston, Massachusetts; Anne McCarthy, University of
Ottawa, Ottawa, Canada; Alejandra Gurtman, Mount Sinai
Medical Center, New York City, New York (October 2002–
August 2005 only); Carmelo Licitra and Antonio Crespo, Or-
lando Regional Health Center, Orlando, Florida; William M.
Stauffer and Patricia F. Walker, University of Minnesota, Min-
neapolis, Minnesota; Thomas B. Nutman and Amy D. Klion,
National Institutes of Health, Bethesda, Maryland; R. Bradley
Sack and Robin McKenzie, Johns Hopkins University, Balti-
more, Maryland (December 1997–August 2007 only); Domi-
nique Meisch, International SOS Clinic, Ho Chi Minh City,
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